130 related articles for article (PubMed ID: 23261050)
1. The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults.
Ambrose CS; Wu X
Vaccine; 2013 Jan; 31(6):857-60. PubMed ID: 23261050
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Nichol KL; Mendelman PM; Mallon KP; Jackson LA; Gorse GJ; Belshe RB; Glezen WP; Wittes J
JAMA; 1999 Jul; 282(2):137-44. PubMed ID: 10411194
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD;
Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
[TBL] [Abstract][Full Text] [Related]
4. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
Mallory RM; Yi T; Ambrose CS
Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB
J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
[TBL] [Abstract][Full Text] [Related]
8. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
[TBL] [Abstract][Full Text] [Related]
9. A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age.
Baxter R; Toback SL; Sifakis F; Hansen J; Bartlett J; Aukes L; Lewis N; Wu X; Ambrose CS
Vaccine; 2012 Apr; 30(20):3053-60. PubMed ID: 22425787
[TBL] [Abstract][Full Text] [Related]
10. Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects.
Block SL; Reisinger KS; Hultquist M; Walker RE;
Antimicrob Agents Chemother; 2007 Nov; 51(11):4001-8. PubMed ID: 17724151
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children.
Block SL; Falloon J; Hirschfield JA; Krilov LR; Dubovsky F; Yi T; Belshe RB
Pediatr Infect Dis J; 2012 Jul; 31(7):745-51. PubMed ID: 22466322
[TBL] [Abstract][Full Text] [Related]
12. Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh.
Ortiz JR; Goswami D; Lewis KD; Sharmeen AT; Ahmed M; Rahman M; Rahman MZ; Feser J; Neuzil KM; Brooks WA
Vaccine; 2015 Jun; 33(29):3415-21. PubMed ID: 25917680
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of intranasal live attenuated influenza vaccine against all-cause acute otitis media in children.
Heikkinen T; Block SL; Toback SL; Wu X; Ambrose CS
Pediatr Infect Dis J; 2013 Jun; 32(6):669-74. PubMed ID: 23271441
[TBL] [Abstract][Full Text] [Related]
14. A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age.
Baxter R; Toback SL; Sifakis F; Hansen J; Bartlett J; Aukes L; Lewis N; Wu X; Ambrose CS
Vaccine; 2012 Apr; 30(19):2989-98. PubMed ID: 22386746
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial.
Brooks WA; Zaman K; Lewis KD; Ortiz JR; Goswami D; Feser J; Sharmeen AT; Nahar K; Rahman M; Rahman MZ; Barin B; Yunus M; Fry AM; Bresee J; Azim T; Neuzil KM
Lancet Glob Health; 2016 Dec; 4(12):e946-e954. PubMed ID: 27746226
[TBL] [Abstract][Full Text] [Related]
16. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer.
Halasa N; Englund JA; Nachman S; Weinberg GA; Huber VC; Allison K; Dubovsky F; Yi T; McCullers JA; Flynn PM
Vaccine; 2011 May; 29(24):4110-5. PubMed ID: 21496468
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older.
De Villiers PJ; Steele AD; Hiemstra LA; Rappaport R; Dunning AJ; Gruber WC; Forrest BD;
Vaccine; 2009 Dec; 28(1):228-34. PubMed ID: 19796721
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*.
Sheldon EA; Jeanfreau R; Sliman JA; Charenkavanich S; Rousculp MD; Dubovsky F; Mallory RM
Influenza Other Respir Viruses; 2013 Nov; 7(6):1142-50. PubMed ID: 23061976
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.
Belshe RB; Ambrose CS; Yi T
Vaccine; 2008 Sep; 26 Suppl 4():D10-6. PubMed ID: 18611422
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies.
Ambrose CS; Wu X; Knuf M; Wutzler P
Vaccine; 2012 Jan; 30(5):886-92. PubMed ID: 22155144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
